Becker Grand Rounds: Wally Pellerite June 30, 2011.

Slides:



Advertisements
Similar presentations
Donna-Bea Tillman AU/OPM II December 2004
Advertisements

Entering the US Market: Medical Devices
Director of Human Resources HR Information and Systems Manager Director of HR Operations Deputy Director of HR Director of Occupational Health EYEC ManagerSafety.
Implementing a PGY-2 Residency Program Critical Care Pharmacy Practice Case Study Kimberly Zammit, PharmD, BCPS.
1 GOOD MORNING! BONJOUR! GOEDEMORGEN!. 2 An Introduction to certain aspects of the US FDA Murray M. Lumpkin, MD Deputy Commissioner International Programs.
Reorganization of APHIS Veterinary Services U.S. Department of Agriculture Animal and Plant Health Inspection Service Veterinary Services November 2013.
Beltway Roundup Changes at FDA Capitol Hill Action Seth A. Mailhot, Counsel, Nixon Peabody LLP, Leader of Nixon Peabody’s FDA Regulatory Practice Team.
FDA Update on Laboratory Developed Tests Oversight Laura M. St. Martin, M.D., M.P.H. Acting Branch Chief, Human Tissues and Reproduction Branch, Division.
Establishment of a Training Dosimetry Laboratory in Cairo University Dr. Hassan Fathy for NSPA.
Introduction to Regulation
0 ADFCA’s Organization Chart OfficeSectorDivision SectionUnit Legal Services Director General Internal Audit Director General’s Office Board of Directors.
Special Topics in IND Regulation
FDA Science Board Advisory Committee Meeting ORA Science Peer Review- Pesticide and Industrial Chemical Programs April 22, 2004.
Vernon D. Toelle, Ph.D. Team Leader Pre-Market Compliance and Administrative Actions Team (BIMO Team) Overview of CVM Bioresearch Monitoring.
Ohio Nano-Summit March 3, 2005 REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D. Associate.
MICHIGAN DEPARTMENT OF AGRICULTURE A NIMAL INDUSTRY DIVISION JOAN M. ARNOLDI, D.V.M., M.S. State Veterinarian and Division Director NANCY A. FRANK, D.V.M.,
Protecting and Promoting Your Health How this work supports FDA’s mission: TO PROMOTE HUMAN and ANIMAL HEALTH by collaborating with veterinary diagnostic.
FDA Resources and Meetings FDA/EMA Orphan Designation and Grant Workshop Silver Spring, Maryland FDA Campus (White Oak) October 12, 2012 Bill Sutton Deputy.
The Changing Food Environment The Role and Activities of the U.S. Food and Drug Administration Transatlantic Consumer Dialogue The Changing Food Environment.
RATIONALIZED ORGANIZATIONAL STRUCTURE
Center for Veterinary Medicine (CVM) RECALLS.  21 CFR 7.40 provides guidance on the policy, procedures, and industry responsibilities for recalls. 
Patient Safety and Medical Devices Sonia Swayze, RN, MA, C and Suzanne Rich, RN, MA, CT.
Future Directions for the Public Health Division Future Directions for the Public Health Division Presentation to the Annual General Meeting Association.
INTRODUCTION TO RA.
Device Clinical Trials and More… Michael E. Marcarelli, PharmD Director, Division of Bioresearch Monitoring Office of Compliance Center for Devices and.
Incident Reports and field Safety Corrective Action ( FSCA) Eng. Essam M. Al-Mohandis Executive Director of Surveillance and Biometrics.
Federal Food, Drug, and Cosmetic Act 1938, 1954, 1958 (FFDCA) Katie Buhai Period 3.
The Research Council of Norway AdministrationCommunication Division for Science Division for Innovation Division for Strategic Priorities Director General.
3/3/2010Handshake to Success Crescent Healthcare is a premier infusion company founded in 1992 to provide home infusion services to patients with chronic.
FDA Science Board Drug Safety Initiative April 15, 2005 Rockville, MD RADM Steven Galson, MD, MPH Acting Director, Center for Drug Evaluation and Research.
The Ministry of Health: Organization. Ministry Central Body of the National Health System Main Tasks: Guarantee all the population equity, quality, effectiveness.
Regulatory Big Brother of Biotechnology. Role of FDA FDA was designed to promote and protect the public’s health Food and Drug Cosmetic Act first passed.
Research, Education & Extension Policy and CSREES Relations Gerald Miller Heartland Regional Water Quality Coordination Initiative and Iowa State University.
PATRICIA KERBY, MPA HUMAN SUBJECTIONS PROTECTION COMPLIANCE OFFICER OFFICE OF RESEARCH COMPLIANCE What are the FDA’s expectations in 2010?
Research Peer-Review at CDER Past and Present Jerry M. Collins, Ph.D. Director, Laboratory of Clinical Pharmacology, OTR Acting Director, Division of Applied.
Latham & Watkins operates as a limited liability partnership worldwide with affiliated limited liability partnerships conducting the practice in the United.
Your College of Medicine Alumni Association 10/26/2015.
Focus on Phase 2 FSMA Implementation
Communicating and Marketing Your Product or Technology in Today’s Healthcare Environment Resources Joni Bradley,
1 CDRH: Minimizing Risk of TSE Agents in Medical Devices CDR Martha O’Lone, RN, BSN CDRH TSE Working Group Chair Infection Control Devices Branch DAGID.
Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation.
1 U.S. Food and Drug Administration International Programs Melinda K. Plaisier Assistant Commissioner for International Programs U.S. Food and Drug Administration.
Nanotechnology - USDA - 18 Nov 2002 REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D.
Mission, Organization, and Operations Presentation by Gray Etheredge and Cathy Chang January 20, 2004.
Enforcement Litigation and Compliance Washington, DC December 9-10, 2015 ORA and FDA District Directors Forum Randy Pack, Director, Compliance Branch,
FACULTY of ARTS and SCIENCES HARVARD BUSINESS SCHOOL GRADUATE SCHOOL OF DESIGN HARVARD DIVINITY SCHOOL Center for the Study of World Religions Summer.
Title Page Quality Mo Samimi, Ph.D. CMQ/OE Presented at the ASQ Biomedical Division Northern California Discussion Group. May 2011.
BIORESEARCH MONITORING & IN VITRO DIAGNOSTIC DEVICES Presented by Jean Toth-Allen, Ph.D. Biophysicist/Consumer Safety Officer Division of Bioresearch Monitoring.
Special Concerns Relating To Promotional Labeling And Advertising For Medical Devices.
The CDRH Software Message (October 19, 2002) John F Murray Jr.. Center for Devices & Radiological Health US Food and Drug Administration
INTRODUCTION Medical Devices ©2014 Salt Lake Community College. All rights reserved.
Good Manufacturing Practices
PHILIPPINES Report: Policies and implementation strategies on HUMAN RESOURCE DEVELOPMENT to introduce NPPs Adopting RAIS 3.2 AS THE NATIONAL REGISTER OF.
FDA Perspective on Cardiovascular Device Development
Integrated Governance Reporting Structures
American Society for Quality Region 5 Quality Conference
CSS Clinical Trial Launched: January 2018
Overview of FDA Food Inspections
Jordan Food & Drug Administration
Hospital Mission The hospital Mission Statement defines the purpose of the hospital’s existence and provides guidance in its community service. All.
Organizational Structure
Beyond Academia.
Maarten Steeghs Senior Advisor Agriculture and Nature Division
Structure of the Internal Audit Service
FDA Resources and Meetings
Patient Involvement in the Development and Safe Use of
Tobey Clark, Director*, Burlington USA
SEIU Local 1000 Summary of the Modifications for the 2009 Budget
Regulation of Private healthcare facilities in hong kong
Conducting Research with Banner Health
Presentation transcript:

Becker Grand Rounds: Wally Pellerite June 30, 2011

FDA Organizational Structure 2 Office of the Commissioner Office of Foods Center for Food Safety & Applied Nutrition Center for Veterinary Medicine Center for Devices & Radiological Health Center for Drug Evaluation & Research National Center for Toxicological Research Center for Tobacco Products Center for Biologics Evaluation & Research Office of Chief Counsel Office of Women’s Health Office of Regulatory Affairs Office of External Affairs Office of Administrative Law Office of Policy, Planning and Budget Office of Legislation Office of the Chief of Staff Office of the Counselor to the Commissioner Office of Special Medical Programs Office of International Programs Office of the Chief Scientist Office of Administration Office of Equal Employment & Diversity Current as of June 9, 2011

Office of Regulatory Affairs 3 Office of Resource Management Office of Enforcement Office of Criminal Investigations Office of Regional Operations Regional Field Office, Central Region Regional Field Office, Northeast Region Regional Field Office, Pacific Region Regional Field Office, Southwest Region Regional Field Office, Southeast Region Current as of June 9, 2011

Center for Devices and Radiological Health 4 Office of the Center Director Office of Management Operations Office of Compliance Office of Device Evaluation Office of Science and Engineering Laboratories Office of Communication, Education, and Radiation Programs Office of Surveillance and Biometrics Office of In Vitro Diagnostic Device Evaluation and Safety CDRH Ombudsman Current as of June 8, 2011

Office of Compliance 5 Division of Enforcement A Division of Enforcement B Division of Risk Management Operations Division of Bioresearch Monitoring Cardiovascular Rhythm & Electrophys. Devices Special Investigations Program Enforcement A Regulatory Policy and Systems Field Operations Recall General Hospital Devices OB/GYN, Gastroenterology & Urology Devices Dental, ENT & Ophthalmic Devices General Surgery Devices Orthopedics and Physical Medicine & Anesthesiology Devices Program Enforcement B Radiology, Anesthesiology & Neurology Devices Vascular and Circulatory Support Devices Office of the Director Current as of June 8, 2011

CDRH Office of Compliance – Office of the Director 6 Director Steven Silverman Deputy Director for Medical Affairs Kimber Richter Deputy Director for Regulatory Affairs Larry Spears Quality Management System Staff Frances Benedict Program Management Staff Marguerite Jones(Acting) Promotion & Advertising Policy Staff Vacant Current as of June 8, 2011